Rocket Pharmaceuticals (RCKT) Granted FDA Regenerative Medicine Advanced Therapy & Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia
Tweet Send to a Friend
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) today announces that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
